CAS: 459836-30-7 - PEAQX
![[[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphon…](https://static.cymitquimica.com/products/IN/thumb/DA003CQ7.jpg)
[[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium hydrate
CAS:459836-30-7
Formula:
C17H17BrN3Na2O6P
Purity:
95%
Color and Shape:
Solid
Molecular weight:
516.1907
Ref: IN-DA003CQ7
| 25mg | 636.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
PEAQX tetrasodium hydrate
CAS:459836-30-7
Formula:
C17H13BrN3Na4O5P·xH2O
Molecular weight:
542.14 (anhydrous)
Ref: 7W-GL2910
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
PEAQX
CAS:459836-30-7
PEAQX (NVP-AAM077) is an oral NMDA antagonist, inhibits 1A/2A receptors (IC50: 270 nM), less so …
Formula:
C17H17BrN3O5P
Purity:
100% - ≥98%
Color and Shape:
Solid
Molecular weight:
454.21
Ref: TM-T4171
| 1mg | 33.00 € | ||
| 2mg | 44.00 € | ||
| 5mg | 72.00 € | ||
| 10mg | 120.00 € | ||
| 25mg | 208.00 € | ||
| 50mg | 323.00 € | ||
| 100mg | 451.00 € | ||
| 200mg | 651.00 € | ||
| 1mL*10mM (DMSO) | 93.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
PEAQX tetrasodium hydrate
CAS:459836-30-7
PEAQX tetrasodium hydrate is a new drug for the treatment of ovarian hyperstimulation syndrome (OHSS) …
Formula:
C17H13BrN3Na4O5P·xH2O
Purity:
Min. 95%
Molecular weight:
542.14 g/mol
Ref: 3D-JTA83630
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
